Scholars@Duke
Journal cover image

MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.

Publication ,  Journal Article
Berk, J; Brinkley-Rubinstein, L; Murphy, M; Chan, P; Rich, J
Published in: Lancet
March 6, 2021
Published version (DOI) Link to item

Duke Scholars

Lauren Brinkley-Rubinstein
Author Lauren Brinkley-Rubinstein Population Health Sciences
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet

DOI

10.1016/S0140-6736(21)00354-8

EISSN

1474-547X

Publication Date

March 6, 2021

Volume

397

Issue

10277

Start / End Page

877 / 878

Location

England

Related Subject Headings

  • SARS-CoV-2
  • Risk Factors
  • Rhode Island
  • Humans
  • General & Internal Medicine
  • Correctional Facilities
  • COVID-19 Drug Treatment
  • Antibodies, Monoclonal
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Berk, J., Brinkley-Rubinstein, L., Murphy, M., Chan, P., & Rich, J. (2021). MAb for symptomatic COVID-19 in correctional facilities: an important opportunity. Lancet, 397(10277), 877–878. https://doi.org/10.1016/S0140-6736(21)00354-8
Berk, Justin, Lauren Brinkley-Rubinstein, Matthew Murphy, Phil Chan, and Josiah Rich. “MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.” Lancet 397, no. 10277 (March 6, 2021): 877–78. https://doi.org/10.1016/S0140-6736(21)00354-8.
Berk J, Brinkley-Rubinstein L, Murphy M, Chan P, Rich J. MAb for symptomatic COVID-19 in correctional facilities: an important opportunity. Lancet. 2021 Mar 6;397(10277):877–8.
Berk, Justin, et al. “MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.” Lancet, vol. 397, no. 10277, Mar. 2021, pp. 877–78. Pubmed, doi:10.1016/S0140-6736(21)00354-8.
Berk J, Brinkley-Rubinstein L, Murphy M, Chan P, Rich J. MAb for symptomatic COVID-19 in correctional facilities: an important opportunity. Lancet. 2021 Mar 6;397(10277):877–878.
Journal cover image

Published In

Lancet

DOI

10.1016/S0140-6736(21)00354-8

EISSN

1474-547X

Publication Date

March 6, 2021

Volume

397

Issue

10277

Start / End Page

877 / 878

Location

England

Related Subject Headings

  • SARS-CoV-2
  • Risk Factors
  • Rhode Island
  • Humans
  • General & Internal Medicine
  • Correctional Facilities
  • COVID-19 Drug Treatment
  • Antibodies, Monoclonal
  • 42 Health sciences
  • 32 Biomedical and clinical sciences